Literature DB >> 24523000

Paroxysmal hemicrania: an update.

Sanjay Prakash1, Rushad Patell.   

Abstract

Paroxysmal hemicrania (PH) is an underreported and underdiagnosed primary headache disorder. It usually begins in the third or fourth decade of life. The recent observations indicate that it is equally prevalent in both males and females. PH is characterized by severe, strictly unilateral head pain attacks that occur in association with ipsilateral autonomic features. The attacks in PH are shorter and more frequent compared with cluster headache (CH) but otherwise PH and CH have similar clinical features. The hallmark of PH is the absolute cessation of the headache with indomethacin. However, a range of drugs may show partial to complete relief in certain groups of patients. Neuromodulatory procedures, such as greater occipital nerve blockade, blockade of sphenopalatine ganglion and neurostimulation of the posterior hypothalamus, are reserved for refractory PH.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24523000     DOI: 10.1007/s11916-014-0407-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  57 in total

1.  Menstrual paroxysmal hemicrania, a possible new entity?

Authors:  F Maggioni; A Palmieri; F Viaro; F Mainardi; G Zanchin
Journal:  Cephalalgia       Date:  2007-07-26       Impact factor: 6.292

Review 2.  Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations.

Authors:  F Antonaci; O Sjaastad
Journal:  Headache       Date:  1989-11       Impact factor: 5.887

3.  Cluster headache and paroxysmal hemicrania: differential diagnosis.

Authors:  J Zidverc-Trajkovic; A M Pavlovic; M Mijajlovic; Z Jovanovic; N Sternic; V S Kostic
Journal:  Cephalalgia       Date:  2005-04       Impact factor: 6.292

4.  Chronic paroxysmal hemicrania and hemicrania continua: anaesthetic blockades of pericranial nerves.

Authors:  F Antonaci; J A Pareja; A B Caminero; O Sjaastad
Journal:  Funct Neurol       Date:  1997 Jan-Feb

Review 5.  A proposal for revision of hemicrania continua diagnostic criteria based on critical analysis of 62 patients.

Authors:  Sanjay Prakash; Purva Golwala
Journal:  Cephalalgia       Date:  2012-06-29       Impact factor: 6.292

6.  Paroxysmal hemicrania in children--symptoms, diagnostic criteria, therapy and outcome.

Authors:  M Blankenburg; T Hechler; G Dubbel; C Wamsler; B Zernikow
Journal:  Cephalalgia       Date:  2009-02-19       Impact factor: 6.292

7.  The paroxysmal hemicrania-tic syndrome.

Authors:  C J Boes; M S Matharu; P J Goadsby
Journal:  Cephalalgia       Date:  2003-02       Impact factor: 6.292

8.  Bilateral paroxysmal cephalalgia: a novel indomethacin-responsive primary headache syndrome?

Authors:  Norazah Abu Bakar; Declan Chard; Manjit S Matharu
Journal:  Cephalalgia       Date:  2012-07-27       Impact factor: 6.292

9.  Diagnostic distribution of 100 unilateral, side-locked headaches consulting a specialized clinic.

Authors:  C Ramón; G Mauri; J Vega; M Rico; M Para; J Pascual
Journal:  Eur Neurol       Date:  2013-02-22       Impact factor: 1.710

Review 10.  Cluster headache, hypothalamus, and orexin.

Authors:  Philip R Holland; Peter J Goadsby
Journal:  Curr Pain Headache Rep       Date:  2009-04
View more
  5 in total

1.  Pediatric paroxysmal hemicrania: a case report and some clinical considerations.

Authors:  Vincenzo Raieli; Vincenzo Cicala; Francesca Vanadia
Journal:  Neurol Sci       Date:  2015-08-12       Impact factor: 3.307

Review 2.  Do trigeminal autonomic cephalalgias represent primary diagnoses or points on a continuum?

Authors:  Larry Charleston
Journal:  Curr Pain Headache Rep       Date:  2015-06

Review 3.  Diagnose and adios: practical tips for the ongoing evaluation and care of TAC patients taking indomethacin.

Authors:  Laura B Xanders; Jessica Ailani
Journal:  Curr Pain Headache Rep       Date:  2015

Review 4.  Side-locked headaches: an algorithm-based approach.

Authors:  Sanjay Prakash; Chaturbhuj Rathore
Journal:  J Headache Pain       Date:  2016-10-21       Impact factor: 7.277

5.  A Combination of Indomethacin Farnesyl and Amitriptyline Is Effective for Continuous Interictal Pain with Probable Chronic Paroxysmal Hemicrania.

Authors:  Shoji Kikui; Junichi Miyahara; Hanako Sugiyama; Mutsuo Kohashi; Kuniko Ota; Daisuke Danno; Yoshihiro Kashiwaya; Takao Takeshima
Journal:  Intern Med       Date:  2021-06-26       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.